Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.6, and our video podcast, CANCER BUZZ TV.
ACCC Precision Medicine: Transforming Complex to Clear



In This Section

Home / Learn / Precision Medicine

Precision Medicine

Precision medicine (also known as personalized medicine) uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat cancer. Precision medicine includes the use of biomarkers, molecular testing, and targeted therapies to deliver a personalized approach to cancer therapy through the use of molecular and genomic information about individual cancers. The National Cancer Institute (NCI) defines precision medicine as “discovering unique therapies that treat an individual’s cancer based on the specific abnormalities of their tumor.”

Transforming Complex to Clear

ACCC develops comprehensive Precision Medicine resources that bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, the resources enable clinicians to make educated and holistic decisions that can positively influence patient outcomes. No matter your learning style—podcasts, on-demand webinars, videos, or publications—the ACCC Precision Medicine Library has resources that provide essential knowledge you can apply to your patient care.

Upcoming Webinars and Events

On-Demand Webinars

Cancer Buzz Podcast

Transforming Complex to Clear: New Precision Medicine Tools

November 09, 2021
Precision Medicine 300x200

The statement, “Precision medicine is revolutionizing patient care,” has at this point perhaps become a bit repetitive. But it’s truer each year. The role of biomarkers and molecular profiling in cancer diagnosis and treatment continues to expand. For five of the most common types of cancer (lung, prostate, colorectal, breast, and skin), there are more than 75 biomarkers used in clinical practice. The sheer number of treatment options across tumor types and the complexity of offering precision medicine services make it difficult for providers to introduce biomarker testing into their practices. 

But biomarker testing can be a game-changer for patients. In oncology, a biomarker can indicate cancer type, how a cancer will progress if left untreated, which specific treatment may be most effective for a given cancer, and how well treatment is working over time. Offering this range of services and the complexity of creating a program for implementing them can be extensive, depending on tumor type and providers' clinical expertise. 

To help community cancer programs and practices that offer, or want to offer, biomarker testing, ACCC has launched Transforming Complex to Clear, a precision medicine campaign that has developed a range of tools and resources to help bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, these resources can enable clinicians to make educated and confident decisions that can positively influence patient outcomes. 

Among these resources is a guide to the lexicon of biomarker testing, an easily searchable, comprehensive guide to biomarker terminology that can help empower the multidisciplinary cancer care team to better serve their patients. “ACCC is focused on reducing barriers to biomarker testing implementation and streamlining verbiage and defining terminology,” explains Michelle Shiller, DO, AP/CP, MGP, chair of the 2020 BiomarkerLive advisory committee. “So all care team members have a shared understanding of precision medicine fundamentals.” 

Precision Medicine Library 

Additional tools and resources available in ACCC’s Precision Medicine Library provide the cancer care team with comprehensive, trusted, and tangible resources that can inform their patient care decisions and help improve outcomes. From toolkits to webinars, the library features resources developed and curated by cancer care experts throughout the world. These resources offer information from pharmacists to oncologists on all aspects of precision medicine, giving providers essential knowledge to apply to patient care. Some of these resources include: 

To access even more archived and new education from ACCC on the topic of precision medicine, explore our website. ACCC’s ongoing precision medicine campaign, Transforming Complex to Clear, will continue by adding additional resources that our members are asking for. Visit us often! 

Featured Opportunity

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management
ACCC—in partnership with the American Society for Clinical Pathology—is committed to providing the resources, tools, and education you need to optimize the diagnosis, testing, and management of patients with advanced NSCLC—particularly those with ALK mutations. Receive up to 4.5 hours of CME/CMLE credit as you increase your knowledge in the testing, treatment, and management of patients with advanced NSCLC.

From Oncology Issues

Digital tools

Biomarker Lexicon
Explore the many terms associated with the different areas and applications of cancer biomarkers.

Biomarker Resource Library
Search this resource bank of nationally available materials relevant to cancer biomarkers and biomarker testing. You may filter by cancer type, area of application, and/or primary audience.

Biomarker Toolkit
This practical toolkit is centered around the four key elements needed to develop a precision medicine program that successfully incorporates biomarker testing.

MRD Testing Implementation Roadmap
Navigate how to lay the groundwork for MRD testing, prepare your care team, implement testing, and evaluate ongoing progress.

MRD Testing Resource Library
Curated materials to help establish and implement MRD testing for your patients with adult B-cell ALL.

Biomarker Testing Implementation Roadmap for Advanced NSCLC
An innovative tool to implement, expand, and sustain biomarker testing for patients with advanced NSCLC.

Biomarker Testing Resource Library
Curated materials to support the implementation of biomarker testing for patients with advanced NSCLC.

Bispecific Antibodies Resources
Links to recent scholarship and resources that can help practices better serve their patients who may be eligible for TRBA therapy.

Abstracts & Presentations

News & Media